Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00445367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biobank For MS And Other Demyelinating Diseases

StatusActive, Not Recruiting
PhaseNot specified
Started2006-05
View on ClinicalTrials.gov ↗
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Amendment record

Amended 19 times since 2007-03-08; most recent filed 2025-09-29. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2025-09-29
Amendment Study Status, Oversight v19
2024-04-18
Amendment Study Status, References v18
2021-07-19
Amendment Study Status v17
2019-07-01
Amendment Study Status v16
2018-01-13
Amendment Study Status, Study Design v15
2016-07-13
Amendment Study Status, Sponsor/Collaborators, Study Design v14
2015-05-01
Amendment Enrolling by Invitation→Active, Not Recruiting Study Status v13
2013-03-05
Amendment Recruiting→Enrolling by Invitation Study Status, Contacts/Locations v12
2012-03-14
Amendment Study Status, Arms and Interventions, Contacts/Locations v11
2010-03-10
Amendment Study Status, Contacts/Locations v10
2009-08-17
Amendment Study Identification, Study Status, Study Design, Eligibility, Contacts/Locations v9
2009-02-05
Amendment Study Status, Contacts/Locations v8
2008-05-08
Amendment Study Status v7
2007-10-26
Amendment Study Status, Study Design, Eligibility v6
2007-08-08
Amendment Study Status, Contacts/Locations v5
2007-07-24
Amendment Study Status, Contacts/Locations v4
2007-06-27
Amendment Study Status, Contacts/Locations v3
2007-06-12
Amendment Study Status, Contacts/Locations v2
2007-05-24
Amendment Study Status, Contacts/Locations v1
2007-03-08
Original filing
Trial Details
NCT Number NCT00445367
Lead Sponsor Accelerated Cure Project for Multiple Sclerosis
Conditions Multiple Sclerosis, Transverse Myelitis, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Optic Neuritis
Enrollment 3,226 participants
Start Date 2006-05
Primary Completion 2030-10 (estimated)
Study Completion 2036-10 (estimated)
Updated on ClinicalTrials.gov 2025-10-02